Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?

References

• Enoch, MA, Johnson K, George DT, Schumann G, Moss HB, Kranzler HR, Goldman D. Ethical considerations for administering alcohol or alcohol cues to treatment-seeking alcoholics in a research setting: can the benefits to society outweigh the risks to the individual? A commentary in the context of the National Advisory Council on Alcohol Abuse and Alcoholism – Recommended Council Guidelines on Ethyl Alcohol Administration in Human Experimentation (2005). Alcohol Clin Exp Res 2009;33:1508–1512.
   PubMed Web of Science ®Google Scholar
• Bacio, GA, Lunny KF, Webb JN, Ray LA. Alcohol use following an alcohol challenge and a brief intervention among alcohol-dependent individuals. Am J Addict 2014;23:96–101.
   PubMed Web of Science ®Google Scholar
• Yardley MM, Ray LA. Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addict Biol 2017;22:581–615.
   Google Scholar
• Perkins, KA, Lerman C, Stitzer ML, Fonte CA, Briski JL, Scott JA, Chengappa KNR. Development of procedures for early screening of smoking cessation medications in humans. Clin Pharmcol Ther 2008;84:216–221.
   PubMed Web of Science ®Google Scholar
• Litten, RZ, Bradley AM, Moss HB. Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol 2012;17:513–527.
   PubMed Web of Science ®Google Scholar
• Mann, K, Lemenager T, Hoffmann S, Reinhard I, Hermann D, Batra A, Berner M, et al. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Addict Biol 2013;18:937–946.
   PubMed Web of Science ®Google Scholar
• Anton, RF, O–Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006;295:2003–2017.
   PubMed Web of Science ®Google Scholar
• Hasin, DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007;64:830–842.
   PubMed Web of Science ®Google Scholar
• Ray LA, Chin PF, Heydari A, Miotto K. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving. Psychopharm 2011;217:341–351.
   Web of Science ®Google Scholar
• Roche DJ, Yardley MM, Lunny KF, Louie SG, Davies DL, Miotto K, Ray LA. A pilot study of the safety and initial efficacy of ivermectin for the treatment of alcohol use disorder. Alcoholism: Clin Exper Res 2016;40:1312–1320.
   PubMed Web of Science ®Google Scholar
• Ray LA, Bujarski S, Shoptaw S, Roche DJ, Heinzerling K, Miotto K. Development of the neuroimmune modulator ibudilast for the treatment of alcoholism: a randomized, placebo-controlled, human laboratory trial. Neuropsychopharmacology 2017; epub.
   Google Scholar
• Sullivan, JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989;84:1353–1357.
   PubMedGoogle Scholar
• Skinner HA, Horn JL. Alcohol Dependence Scale (ADS) user’s guide. Toronto, Canada: Addiction Research Foundation; 1984.
   Google Scholar
• Miller WR, Tonigan JS, Longabaugh R. The Drinker Inventory of Consequences (DrInC): an instrument for assessing adverse consequences of alcohol abuse: Test manual. Rockville, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; 1995.
   Google Scholar
• Sobell, MB, Sobell LC, Klajner F, Pavan D, Basian E. The reliability of a timeline method for assessing normal drinker college students’ recent drinking history: utility for alcohol research. Addict Behav 1986;11:149–161.
   PubMed Web of Science ®Google Scholar
• Anton RF, Moak DH, Latham PK. The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 1996;53:225–231.
   PubMed Web of Science ®Google Scholar
• First, MB, Spitzer RI, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition, January 1995 FINAL, SCID-I/P Version 2.0. New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1995.
   Google Scholar
• Miller WR, Tonigan JS. Assessing drinkers’ motivation for change: the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). Psychol Addict Behav 1996;10:81–89.
   Web of Science ®Google Scholar
• R Core Team. R: A Language and environment for statistical computing. 2016, R Foundation for Statistical Computing. Available from: https://www.R-project.org.
   Google Scholar
• Del Re AC compute.es: Compute Effect Sizes. 2013, R Package 0.2-2. Available from: http://cran.r-project.org/web/packages/compute.es.
   Google Scholar
• Signorell, A, Aho K, Alfons A, Anderegg N, Aragon T, Arppe A, Baddeley A, et al. DescTools: tools for descriptive statistics, R package version 0.99.18; 2016. Available at https://cran.r-project.org/package=DescTools
   Google Scholar
• Peugh JL. A practical guide to multilevel modeling. J Sch Psychol 2010;48:85–112.
   PubMed Web of Science ®Google Scholar
• Verhoeven KJF, Simonsen KL, Mcintyre LM. Implementing false discovery rate control: increasing your power. Oikos 2005;108:643–647.
   Web of Science ®Google Scholar
• Subbaraman, MS, Lendle S, Laan M, Kaskutas LA, Ahern J. Cravings as a mediator and moderator of drinking outcomes in the COMBINE study. Addiction 2013;108:1737–1744.
   PubMed Web of Science ®Google Scholar
• Roos CR, Mann K, Witkiewitz K. Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone. Addict Biol 2016; epub. doi:10.1111/abd.12427.
   Google Scholar
• Worley, MJ, Witkiewitz K, Brown SA, Kivlahan DR, Longabaugh R. Social network moderators of naltrexone and behavioral treatment effects on heavy drinking in the COMBINE study. Alcohol Clin Exp Res 2015;39:93–100.
   PubMed Web of Science ®Google Scholar
• Gueorguieva, R, Wu R, Tsai WM, O’Connor PG, Fucito L, Zhang H, O’Malley SS. An analysis of moderators in the COMBINE study: identifying subgroups of patients who benefit from acamprosate. Eur Neuropsychopharmacol 2015;25:1586–1599.
   PubMed Web of Science ®Google Scholar
• Plebani, JG, Ray LA, Morean ME, Corbin WR, MacKillop J, Amlung M, King AC. Human laboratory paradigms in alcohol research. Alcohol Clin Exp Res 2012;36:972–983.
   PubMed Web of Science ®Google Scholar
• Rohn, MCH, Lee MR, Kleuter SB, Schwandt ML, Falk DE, Leggio, L. Differences between treatment-seeking and nontreatment-seeking alcohol dependent research participants: an exploratory analysis. Alcohol Clin Exp Res 2017;41:414–420.
   Google Scholar
• Fein G, Landman B. Treated and treatment-naïve alcoholics come from different populations. Alcohol 2005;36:19–26.
   PubMed Web of Science ®Google Scholar
• Grant, BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, Pickering RP, et al. Epidemiology of DSM-5 Alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III. JAMA Psychiat 2015;72:757–766.
   PubMed Web of Science ®Google Scholar
• Pratt WM, Davidson D. Does participation in an alcohol administration study increase risk for excessive drinking?. Alcohol 2005;37:135–141.
   PubMed Web of Science ®Google Scholar
• Sommer, C, Seipt C, Spreer M, Blümke T, Markovic A, Jünger E, Plawecki M, Zimmermann US. Laboratory alcohol self-administration experiments do not increase subsequent real-life drinking in young adult social drinkers. Alcohol Clin Exp Res 2015;39:1057–1063.
   PubMed Web of Science ®Google Scholar